top of page

PROGRAMME   
EHMSG Workshop

Friday, September 11, 2026

 

08.25 – 08.30 hrs              

Welcome by EHMSG President Mirjana Rajilić-Stojanović, Belgrade, Serbia

08.30 – 10.20 hrs   Session 01 – Microbiota & Metabolic Syndrome

08.30 – 08.50 hrs                 

01.01. Gut microbiota and metabolic disorders: pathophysiological insights

Herbert Tilg, Innsbruck, Austria

08.50 – 09.10 hrs                 

01.02. Helicobacter pylori and Metabolic Syndrome

Francesco Franceschi, Rome, Italy

09.10 – 09.30 hrs                 

01.03. Gut Microbiota Metabolism and Metabolic Diseases
tbc

09.30 – 09.50 hrs                 

01.04. Approved Therapies for Metabolic Syndrome Management

tbc

09.50 – 10.05 hrs

01.05. Talk from Submitted Abstracts

 

10.05 – 10.20 hrs

01.06. Talk from Submitted Abstracts

10.20 – 11.00 hrs | Coffee Break

 

11.00 – 12.25 hrs   Session 02 – New Targets for Clinical Applications in FMT (Parallel Session)

11.00 – 11.20 hrs              

02.01. FMT in oncology

Serena Porcari, Rome, Italy

11.20 – 11.40 hrs                 

02.02. FMT in noncommunicable disorders

Nicolas Benech, Lyon, France

11.40 – 11.55 hrs                 

02.03. Talk from Submitted Abstracts

 

11.55 – 12.10 hrs                 

02.04. Talk from Submitted Abstracts

12.10 – 12.25 hrs                 

02.05. Talk from Submitted Abstracts

11.00 – 12.25 hrs | Session 03 – Unfinished Agenda for Helicobacter pylori (Parallel Session)

11.00 – 11.20 hrs              

03.01. Optimizing Current Helicobacter pylori Therapies: Strategies to Improve Efficacy in Clinical Practice

Theodore Rokkas, Athens, Greece

11.20 – 11.40 hrs                 

03.02. Helicobacter pylori Search-and-Treat Policy: Current Challenges

Colm O’Morain, Dublin, Ireland

11.40 – 11.55 hrs                 

03.03. Talk from Abstracts

11.55 – 12.10 hrs                 

03.04. Talk from Submitted Abstracts

12.10 – 12.25 hrs                 

02.05. Talk from Submitted Abstracts

12.25 – 14.00 hrs | Lunch Break & Poster Viewing

 

14.00 – 15.00 hrs   Session 04 – Industry-Sponsored Satellite Symposium 

15.00 – 16.25 hrs   Session 05 – New Guidance and Regulation of FMT  (Parallel Session)

15.00 – 15.20 hrs                 

05.01. Update on the regulatory aspects of FMT

Simon Mark Baunwall, Aarhus, Denmark

15.20 – 15.40 hrs                 

05.02. How to build a FMT centre: the Eastern Europe experience

Georgiana-Emmanuela Gilca-Blanariu, Iasi, Romania

 

15.40 – 15.55 hrs                 

05.03. Talk from Submitted Abstracts

15.55 – 16.10 hrs                 

05.04. Talk from Submitted Abstracts

16.10 – 16.25 hrs                 

05.05. Talk from Submitted Abstracts

15.00 – 16.30 hrs   Session 06 – Helicobacter pylori Screening  (Parallel Session)

15.00 – 15.20 hrs                 

06.01. Risk of Gastric Adenocarcinoma after Eradication of Helicobacter pylori

tbc

 

15.20 – 15.40 hrs                 

06.02. New EU Gastric Cancer Prevention Guidelines

Marcis Leja, Riga, Latvia

15.40 – 16.00 hrs                 

06.03. Korean Registry on the Current Management of Helicobacter pylori (K-Hp-Reg)

Joon Sung Kim, Seoul, Korea

16.00 – 16.15 hrs                 

06.04. Talk from Submitted Abstracts

16.15 – 16.30 hrs                 

06.05. Talk from Submitted Abstracts

16.30 – 17.00 hrs | Coffee Break

 

17.00 – 18.40 hrs   Session 07 – Antimicriobial Resistance in Helicobacter pylori and Microbiota

17.00 – 17.20 hrs                 

07.01. The impact of travelling on resistome

John Penders, Maastricht, Netherlands

17.20 – 17.40 hrs                 

07.02. Antimicrobial Treatment and Resistome

Ioanna Chatzigiannidou, Lyngby, Denmark                                             

17.40 – 18.00 hrs                 

07.03. The optimization of helicobacter eradication therapy based on the results of KCAST-HP

Ji Jong Ahn, Seoul, Korea             

18.00 – 18.20 hrs                 

07.04. Challenges for Helicobacter pylori Resistance

Christian Schulz, Munich, Germany

 

18.20 – 18.40 hrs                 

07.05. Helicobacter pylori Resistance in Patients with Therapeutic Failure – Results from Tertiary Center in Serbia

Dragana Mijač, Belgrade, Serbia

 

20.00 hrs | Conference Dinner

 

 

Saturday, September 12, 2026


08.30 - 09.50 hrs   Session 08 - Oncobiome

08.30 – 08.50 hrs                 

08.01. Microbiome in Immune Checkpoint Inhibition

Johannes Björk, Groningen, Netherlands

08.50 – 09.10 hrs                 

08.02. Microbiome Immune Interactions in Cancer

tbc

09.10 – 09.30 hrs                 

08.03. Intra-Tumoral Microbiome

Emilie Bessède, Bordeaux, France

 

09.30 – 09.50 hrs                 

08.04. Streptococcus Anginosus Role in Gastric Cancer

tbc

09.50 – 10.20 hrs | Coffee Break

 

10.20 – 11.45 hrs   Session 09 – Microbiome as a Biomarker (Parallel Session)

10.20 – 10.40 hrs              

09.01. Evaluating Microbial Dysbiosis through Meta-Analysis

Georgina Hold, Sydney, Australia

10.40 – 11.00 hrs                 

09.02. Microbiome Testing in Clinical Practice

Juozas Kupcinskas, Kaunas, Lithuania

 

11.00 – 11.15 hrs                 

09.03. Talk from Submitted Abstracts

11.15 – 11.30 hrs                 

09.04. Talk from Submitted Abstracts

11.30 – 11.45 hrs                 

09.05. Talk from Submitted Abstracts

 

10.20 -11.45 hrs   Session 10 – AI in Helicobacter pylori (Parallel Session)

10.20 – 10.40 hrs                 

10.01. Can AI be the Pathologist Friend?

Ari Ristimäki, Helsinki, Finland

10.40 – 11.00 hrs                 

10.02. AI in Endoscopy

Yoshio Yamaoka, Yufu, Japan

 

11.00 – 11.15 hrs                 

10.03. Talk from Submitted Abstracts

11.15 – 11.30 hrs                 

10.04. Talk from Submitted Abstracts

11.30 – 11.45 hrs                 

10.05. Talk from Submitted Abstracts

11.45 – 13.30 hrs | Lunch Break & Poster Viewing

 

13.30 – 14.55 hrs   Session 11 – Probiotics (Parallel Session)

13.30 – 13.50 hrs                 

11.01. Next Generation Probiotics and Aging       

Miroslav Dinić, Belgrade, Serbia

13.50 – 14.10 hrs                 

11.02. Psychobiotics

Gerard Clarke, Cork, Ireland

14.10 – 14.25 hrs                 

11.03. Talk from Submitted Abstracts

 

14.25 – 14.40 hrs                 

11.04. Talk from Submitted Abstracts

14.40 – 14.55 hrs                 

11.05. Talk from Submitted Abstracts

 

13.30 – 14.55 hrs | Session 12 – Gastric Cancer and Helicobacter pylori (Parallel Session)

13.30 – 13.50 hrs                 

12.01. Mucosal Immunity and Helicobacter Pylori

Raquel Mejias-Luque, Munich, Germany

13.50 – 14.10 hrs                 

12.02. The Role of the Tumor Microenvironment in Gastric Carcinogenesis

Martijn Gloerich, Utrecht, Netherlands       

 

14.10 – 14.25 hrs                 

12.03. Talk from Submitted Abstracts

14.25 – 14.40 hrs                 

12.04. Talk from Submitted Abstracts

14.40 – 14.55 hrs                 

12.05. Talk from Submitted Abstracts

14.55 – 15.30 hrs | Coffee Break

 

15.30 – 16.30 hrs   Session 13 – Progress in Helicobacter pylori research: Maastricht 1996 - 2026

15.30 – 15.50 hrs                 

13.01. Diagnostics

Francis Mégraud, Bordeaux, France

15.50 – 16.10 hrs                 

13.02. Therapeutics

Colm O’Morain, Dublin, Ireland

16.10 – 16.30 hrs                 

13.03. Clinical Strategies

Peter Malfertheiner, Munich, Germany

 

16.30 – 18.00 hrs   Session 14 – Closing Session

16.30 – 16.55 hrs   

14.01. Awarding of the Marshall and Warren Medal 2026 to Tomica Milosavljevic, Belgrade, Serbia

16.30 – 16.40 hrs                            

Introduction by Peter Malfertheiner, Munich, Germany

16.40 – 16.55 hrs                            

Short talk Tomica Milosavljevic, Belgrade, Serbia                                  

 

16.55 – 17.15 hrs                 

14.02. Awarding of the EHMSG Oral and Poster Awards

Poster Jury:

  • Gianluca Ianiro, Rome, Italy

  • Christian Schulz, Munich, Germany

  • Sinead Smith, Dublin, Ireland


17.15 – 17.30 hrs                 

14.03. Presentation of the EHMSG Journal

Francesco Franceschi, Rome, Italy


17.30 – 17.45 hrs                 

14.04. Presentation of the next meeting in Athens

Theodore Rokkas, Athens, Greece

17.45 – 18.00 hrs

Closing Remarks

© 2026 EHMSG

The EHMSG is a member of the United European Gastroenterology, a professional non-profit organisation combining all the leading European societies concerned with digestive disease.
UEG represents over 22,000 specialists, working across medicine, surgery, paediatrics, GI oncology and endoscopy. This makes UEG the most comprehensive organisation of its kind in the world, and a unique platform for collaboration and the exchange of knowledge.

ueglogomember.jpg
  • Twitter
bottom of page